Home > News > BioSante Pharmaceuticals Announces Publication of Oral Insulin Study
June 1st, 2004
BioSante Pharmaceuticals Announces Publication of Oral Insulin Study
BioSante Pharmaceuticals, Inc. announced today the publication of positive results of a preclinical study of its proprietary calcium phosphate nanoparticle (CAP) delivery system for the oral delivery of insulin in the June 11 issue of the peer-reviewed International Journal of Pharmaceutics.
New, old science combine to make faster medical test: Nanoparticles and Faraday rotation allow faster diagnoses January 23rd, 2017
New research helps to meet the challenges of nanotechnology: Research helps to make the most of nanoscale catalytic effects for nanotechnology January 20th, 2017
Chemists Cook up New Nanomaterial and Imaging Method: Nanomaterials can store all kinds of things, including energy, drugs and other cargo January 19th, 2017
'5-D protein fingerprinting' could give insights into Alzheimer's, Parkinson's January 19th, 2017